These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19730035)

  • 1. CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals.
    Kaur-Knudsen D; Nordestgaard BG; Tybjaerg-Hansen A; Bojesen SE
    Pharmacogenet Genomics; 2009 Sep; 19(9):685-94. PubMed ID: 19730035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
    Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.
    Kjaergaard AD; Ellervik C; Tybjaerg-Hansen A; Axelsson CK; Grønholdt ML; Grande P; Jensen GB; Nordestgaard BG
    Circulation; 2007 Feb; 115(7):861-71. PubMed ID: 17309937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenomics J; 2009 Oct; 9(5):327-32. PubMed ID: 19652664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
    Justenhoven C; Pierl CB; Haas S; Fischer HP; Baisch C; Hamann U; Harth V; Pesch B; Brüning T; Vollmert C; Illig T; Dippon J; Ko YD; Brauch H
    Breast Cancer Res Treat; 2008 Sep; 111(1):171-7. PubMed ID: 17922187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
    McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
    Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.
    Harth V; Schafer M; Abel J; Maintz L; Neuhaus T; Besuden M; Primke R; Wilkesmann A; Thier R; Vetter H; Ko YD; Bruning T; Bolt HM; Ickstadt K
    J Toxicol Environ Health A; 2008; 71(13-14):887-97. PubMed ID: 18569591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
    Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
    Rylander-Rudqvist T; Wedren S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
    Carcinogenesis; 2003 Sep; 24(9):1533-9. PubMed ID: 12844487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.
    Economopoulos KP; Sergentanis TN
    Breast Cancer Res Treat; 2010 Jul; 122(2):545-51. PubMed ID: 20054638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Mishra BN; Pant MC; Parmar D
    Mutat Res; 2008 Aug; 643(1-2):4-10. PubMed ID: 18573508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.
    Freiberg JJ; Tybjaerg-Hansen A; Sillesen H; Jensen GB; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):990-6. PubMed ID: 18276912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer?
    Thier R; Brüning T; Roos PH; Bolt HM
    Arch Toxicol; 2002 Jun; 76(5-6):249-56. PubMed ID: 12107641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 1B1 and 2C9 genotypes and risk of ischemic vascular disease, cancer, and chronic obstructive pulmonary disease.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Curr Vasc Pharmacol; 2012 Jul; 10(4):512-20. PubMed ID: 22272893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the Cyp1B1 L432V gene polymorphism and exposure to tobacco smoke on Cyp1B1 mRNA expression in human leukocytes.
    Helmig S; Hadzaad B; Döhrel J; Schneider J
    Drug Metab Dispos; 2009 Jul; 37(7):1490-5. PubMed ID: 19349377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphic markers of the CYP1B1 (4326C > G), CYP2F1 (c.14_15insC), CYP2J2 (-76G > T), and CYP2S1 (13106C > T and 13255A > G) genes and genetic predisposition to chronic respiratory diseases induced by smoking and occupational factors].
    Akhmadishina LA; Korytina GF; Victorova TV
    Genetika; 2011 Oct; 47(10):1402-10. PubMed ID: 22232929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
    Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
    Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.